Literature DB >> 1174463

Pathological changes in pregnant mice infected with Coxsackievirus B3 and given dietary casein hydrolysate supplement.

A B Lansdown.   

Abstract

Coxsackievirus B3 infection in pregnant mice leads to a severe pancreatic exocrine insufficiency in the mothers and retarded foetal growth. As a consequence of the pancreatic damage, the animals are rendered incapable of digesting sufficient amounts of dietary proteins to allow maternal liver development to proceed as normal for the pregnant rodent. Faecal nitrogen was increased and the maternal livers were small for the weights of the animals and exhibited a lower than normal nitrogen content. Feeding of additional amino acids and simple peptides in the diet in the form of casein hydrolysate either from before or after virus injection appeared to compensate for the inability of these animals to digest dietary protein nitrogen and allowed maternal liver development and foetal growth to proceed at a rate not significantly different from normal. Although these results apply to infections with Coxsackievirus B3 in pregnancy, they may be relevant to other infections which adversely affect foetal growth by their pathological effects on maternal organs necessary for maintaining optimal foetal growth.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174463      PMCID: PMC2072754     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  Mitigation of virus-induced foetal growth retardation in mice by dietary casein hydrolysate.

Authors:  A B Lansdown; C R Coid; D B Ramsden
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

2.  [Chronic fibroelastic myoendocarditis of the newborn and the infant (fibroelastosis). New morphological, etiological and pathogenic data. Relation to certain cardiac abnormalities].

Authors:  L FRUHLING; R KORN; J LAVILLAUREIX; A SURJUS; S FOUSSEREAU
Journal:  Ann Anat Pathol (Paris)       Date:  1962 Apr-Jun

3.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

4.  Fetal mouse weights and albumin-alpha 1-fetoprotein ratios after maternal infection with Coxsackievirus B3.

Authors:  C R Coid; D B Ramsden; M J Healy
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

5.  Pathological changes in pregnant mice infected with Coxsackie B3 virus as a possible cause of retarded foetal development.

Authors:  A B Lansdown; C R Coid
Journal:  Br J Exp Pathol       Date:  1974-04

6.  Retardation of foetal growth and plasma protein development in foetuses from mice injected with Coxsackie B3 virus.

Authors:  C R Coid; D B Ramsden
Journal:  Nature       Date:  1973-02-16       Impact factor: 49.962

7.  Relationship of congenital anomalies and maternal infection with selected enteroviruses.

Authors:  G C Brown; R S Karunas
Journal:  Am J Epidemiol       Date:  1972-03       Impact factor: 4.897

8.  Influence of time of infection during pregnancy with coxsackievirus B3 on maternal pathology and foetal growth in mice.

Authors:  A B Lansdown
Journal:  Br J Exp Pathol       Date:  1975-04
  8 in total
  1 in total

1.  Immunization of mice against Coxsackievirus B3 and prevention of foetal growth retardation.

Authors:  A B Lansdown; J D Brown
Journal:  Br J Exp Pathol       Date:  1976-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.